# Wilson S. Colucci

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/wilson-s-colucci/

## Facts

| Field | Value |
| --- | --- |
| Citations | 42,780 |
| Field | Cardiovascular Function and Risk Factors |
| h-index | 107 |
| i10-index | 269 |
| Last Known Institution | Boston University |
| OpenAlex ID | https://openalex.org/A5031837459 |
| ORCID iD | https://orcid.org/0000-0002-0576-9420 |
| Works | 442 |

## Researcher papers

- [The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure](https://scholariq.org/papers/the-effect-of-carvedilol-on-morbidity-and-mortality-in-patients-with-chronic/)
- [Targeted Anticytokine Therapy in Patients With Chronic Heart Failure](https://scholariq.org/papers/targeted-anticytokine-therapy-in-patients-with-chronic-heart-failure/)
- [Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure](https://scholariq.org/papers/intravenous-nesiritide-a-natriuretic-peptide-in-the-treatment-of-decompensated/)
- [Mitochondrial function as a therapeutic target in heart failure](https://scholariq.org/papers/mitochondrial-function-as-a-therapeutic-target-in-heart-failure/)
- [Adiponectin-mediated modulation of hypertrophic signals in the heart](https://scholariq.org/papers/adiponectin-mediated-modulation-of-hypertrophic-signals-in-the-heart/)
- [Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure](https://scholariq.org/papers/carvedilol-inhibits-clinical-progression-in-patients-with-mild-symptoms-of-heart/)
- [Double-Blind, Placebo-Controlled Study of the Effects of Carvedilol in Patients With Moderate to Severe Heart Failure](https://scholariq.org/papers/double-blind-placebo-controlled-study-of-the-effects-of-carvedilol-in-patients/)
- [Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy.](https://scholariq.org/papers/endothelium-dependent-dilation-of-the-coronary-microvasculature-is-impaired-in/)
- [Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial](https://scholariq.org/papers/digoxin-and-reduction-in-mortality-and-hospitalization-in-heart-failure-a/)
- [Sustained Effectiveness of Converting-Enzyme Inhibition in Patients with Severe Congestive Heart Failure](https://scholariq.org/papers/sustained-effectiveness-of-converting-enzyme-inhibition-in-patients-with-severe/)
- [Mineralocorticoid Receptor Inhibition Ameliorates the Transition to Myocardial Failure and Decreases Oxidative Stress and Inflammation in Mice With Chronic Pressure Overload](https://scholariq.org/papers/mineralocorticoid-receptor-inhibition-ameliorates-the-transition-to-myocardial/)

## Researcher topics

- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiac Fibrosis and Remodeling](https://scholariq.org/topics/cardiac-fibrosis-and-remodeling/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Cardiac Ischemia and Reperfusion](https://scholariq.org/topics/cardiac-ischemia-and-reperfusion/)

## Researcher university

- [Boston University](https://scholariq.org/institutions/boston-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.